{
    "title": "Innovative Data Featuring Nanox AI Cardiac Solution Showcased at SCCT 2024",
    "url": "https://www.globenewswire.com/news-release/2024/07/25/2918785/0/en/Innovative-Data-Featuring-Nanox-AI-Cardiac-Solution-Showcased-at-SCCT-2024.html",
    "publishedAt": "2024-07-25T12:00:00Z",
    "content": "July 25, 2024 08:00 ET\n\n\r\n            | Source:\r\n            \nNano-X Imaging LTD.\n\n\n\n\n\nNano-X Imaging LTD.\nIn a study conducted by Brigham & Women’s Hospital, Nanox.AI-Based Analysis helps Reveal Coronary Artery Calcium in over 50% of IMID Patients; Lead author Brittany Weber, MD, PhD, declared as ‘Young Investigator Awards’ Winner\nIn a study conducted by Jefferson Einstein Hospital, Nanox.AI Cardiac Solution Flags CAD High-Risk Patients, Drives Significant Revenue\nAdditional data presented by Corewell Health, Massachusetts General Hospital and Rabin Medical Center\nPETACH TIKVA, Israel, July  25, 2024  (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox.AI Ltd., was highlighted in multiple scientific presentations at the 2024 Society of Cardiovascular Computed Tomography (SCCT) Annual Meeting.\n“We are encouraged by the implementation of our AI cardiac solution at esteemed healthcare systems, along with the continued validation through real-world studies of its potential to promote early detection and preventive care of cardiovascular disease,” said Erez Meltzer, Nanox Chief Executive Officer and Acting Chairman. “We would also like to thank SCCT for the opportunity to showcase the outstanding clinical results of our AI cardiac solution.”\nFindings presented at SCCT 2024 include:\nPrevalence and Prognostic Implications of Incidentally Detected Coronary Artery Calcium Using Artificial Intelligence Analysis Among Individuals with Immune Mediated inflammatory Diseases\nOptimizing Preventive Cardiology: Harnessing AI for Early Detection of Coronary Artery Disease\nAI Empowering Early Detection of CAD Patients for Improved Cardiac Care\nArtificial–Intelligence-based Detection of Coronary Artery Calcium on Chest CT to Enhance Cardiovascular Risk Assessment of Individuals with Elevated Lipoprotein (a)\nOpportunistic Screening of Coronary Artery Calcification on Non-gated Conventional CT scans Using Artificial Intelligence\nAbout Nanox.AINanox.AI is the deep-learning medical imaging analytics subsidiary of Nanox. Nanox.AI’s solutions are developed to target highly prevalent chronic and acute diseases affecting large populations around the world. Leveraging AI technology, Nanox.AI helps clinicians extract valuable and actionable clinical insights from routine medical imaging that otherwise may go unnoticed, potentially initiating further medical assessment to establish individual preventative care pathways for patients. For more information, please visit https://www.nanox.vision/ai.\nAbout NanoxNanox (NASDAQ: NNOX) is focused on applying its proprietary medical imaging technology and solutions to make diagnostic medicine more accessible and affordable across the globe. Nanox’s vision is to increase access, reduce costs and enhance the efficiency of routine medical imaging technology and processes, to improve early detection and treatment, which Nanox believes is key to helping people achieve better health outcomes, and, ultimately, to save lives. The Nanox ecosystem includes Nanox.ARC— a multi-source Digital Tomosynthesis system that is cost-effective and user-friendly; an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic disease (Nanox.AI); a cloud-based infrastructure (Nanox.CLOUD); and a proprietary decentralized marketplace, through Nanox’s subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts; and a comprehensive teleradiology services platform (Nanox.MARKETPLACE). Together, Nanox’s products and services create a worldwide, innovative, and comprehensive solution that connects medical imaging solutions, from scan to diagnosis. For more information, please visit www.nanox.vision.\nContacts\nMedia Contact:Ben ShannonICR WestwickeNanoxPR@icrinc.com\nInvestor Contact:Mike CavanaughICR Westwickemike.cavanaugh@westwicke.com"
}